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ABSTRACT
Background: Knowledge on resting energy expenditure (REE) in
spinal muscular atrophy type I (SMAI) is still limited. The lack of a
population-specific REE equation has led to poor nutritional support
and impairment of nutritional status.
Objective: To identify the best predictors of measured REE (mREE)
among simple bedside parameters, to include these predictors in
population-specific equations, and to compare such models with the
common predictive equations.
Methods: Demographic, clinical, anthropometric, and treatment
variables were examined as potential predictors of mREE by indirect
calorimetry (IC) in 122 SMAI children consecutively enrolled in
an ongoing longitudinal observational study. Parameters predicting
REE were identified, and prespecified linear regression models
adjusted for nusinersen treatment (discrete: 0 = no; 1 = yes) were
used to develop predictive equations, separately in spontaneously
breathing and mechanically ventilated patients.
Results: In naïve patients, the median (25th, 75th percentile)
mREE was 480 (412, 575) compared with 394 (281, 554) kcal/d
in spontaneously breathing and mechanically ventilated patients,
respectively (P = 0.009). In nusinersen-treated patients, the median
(25th, 75th percentile) mREE was 609 (592, 702) compared with
639 (479, 723) kcal/d in spontaneously breathing and mechanically
ventilated patients, respectively (P = 0.949). Both in spontaneously
breathing and mechanically ventilated patients, the best prediction of
REEwas obtained from 3models, all using as predictors: 1 body size
related measurement and nusinersen treatment status. Nusinersen
treatment was correlated with higher REE both in spontaneously
breathing and mechanically ventilated patients. The population-
specific equations showed a lower interindividual variability of the
bias than the other equation tested, however, they showed a high root
mean squared error.
Conclusions: We demonstrated that ventilatory status, nusinersen
treatment, demographic, and anthropometric characteristics deter-
mine energy requirements in SMAI. Our SMAI-specific equations
include variables available in clinical practice and were generally
more accurate than previously published equations. At the individual
level, however, IC is strongly recommended for assessing energy
requirements. Further research is needed to externally validate these
predictive equations. Am J Clin Nutr 2020;00:1–14.
Keywords: spinal muscular atrophy type I, resting energy expendi-
ture, predictive equations, nutritional status, nusinersen
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Introduction
Spinal muscular atrophy (SMA) is a rare autosomal recessive
neurodegenerative disease characterized by the degeneration
of spinal cord motor neurons, atrophy of skeletal muscles,
and generalized weakness (1). SMA is caused by deletion,
conversion, or mutation of the survival motor neuron 1 (SMN1)
gene (2). SMA type I (SMAI), together with the prenatal type 0,
is the most severe phenotype of the 5 forms of SMA. Children
with SMAI show hypotonia and muscle weakness at birth or
within the first months of life, never acquire the independent
sitting position, and show progressive difficulty in breathing
and swallowing (3), requiring early mechanical ventilation and
artificial feeding (4). Both over- and undernutrition are reported
in SMA (5, 6), suggesting a multifactorial impairment that can
produce very different nutritional phenotypes. Until recently,
multidisciplinary supportive care was the only option to manage
the respiratory, nutritional, and orthopedic comorbidities, but
between 2016 and 2017 nusinersen treatment was approved
by the FDA and the European Medicines Agency. Nusinersen
is an antisense oligonucleotide designed to modulate pre-
mRNA splicing of the SMN2 gene, for treatment of all SMA
types. Although nusinersen is not a definitive cure, clinical
trials have demonstrated significant improvements in survival
and motor function, particularly in patients treated promptly
(7, 8).
There is a significant gap in knowledge regarding energy
requirement estimations in SMA; therefore, it is not usually
possible to prescribe the optimal energy intake for SMA patients
according to their specific energy requirements. The dietary
clinical management in SMAI patients is also hampered by
their abnormalities in body composition. As previously demon-
strated (9, 10), SMAI patients can appear severely underweight
compared with healthy children’s growth charts, due to the
disproportion in fat mass (FM) and fat-free mass (FFM) (10).
This imbalance leads to the misinterpretation of nutritional status
and the imprecise determination of resting energy expenditure
(REE).
The gold standard method for the determination of REE is
indirect calorimetry (IC) (11); however, IC devices are rarely
available in clinics, and nutritional care professionals often have
to rely on predictive equations to estimate REE. WHO (12) and
Schofield (13) equations have been studied to a limited extent
in treatment-naïve SMA patients, all showing overestimation of
energy requirements compared with REE obtained by IC (4, 14,
15). The International Standards of Care for SMA recommended
9–11 kcal/height (cm) regardless of age, sex, and clinical status
(16), without external validation studies confirming this energy
recommendation. Essentially, there are currently no predictive
equations specifically developed for the estimation of REE in
SMAI patients.
The primary aim of this study was to develop a predictive
energy equation for SMAI children.We therefore investigated the
most relevant predictors of measured resting energy expenditure
(mREE) among various demographic, anthropometric, and
clinical variables, including nusinersen treatment and type of
feeding and breathing. The secondary aim was to establish the
overall precision of our predictive energy equation in comparison
with other commonly used equations.
Methods
Sample and study design
Since April 2015, a longitudinal observational study in SMA
children has been conducted at the International Center for
the Assessment of Nutritional Status (ICANS), University of
Milan. On 18 January, 2019, 158 patients with a clinical and
genetic diagnosis of SMAI were consecutively enrolled; patients
were included in the present study according to the following
inclusion criteria: Caucasian children with a body weight of
≥5 kg, age lower than 10 y, absence of acute infections, no
inclusion in ongoing experimental pharmacological trials, and
clinical management according to the guidelines set out in the
Consensus Statement for Standard of Care in SMA (17–19).
Patients under nusinersen treatment had received ≥4 loading
doses. Patients with hemodynamic or respiratory instability or
ventilated with an inspiratory oxygen fraction (FIO2) >0.6 or
positive end-expiratory pressure (PEEP)>10 cm H2O were also
excluded in order to avoid measurement errors due to gas leaks
and hypercatabolic status.
The participant flow chart is available as online supporting
material (Supplementary Figure 1).
Patients
Patients were recruited from 5 clinical referral centers for SMA
in Italy (Developmental Neurology Unit, Fondazione IRCCS
Istituto Neurologico Carlo Besta, Milan; SAPRE UONPIA,
Fondazione IRCSS Cà Granda, Policlinico di Milano, Milan;
Department of Neurosciences, Neuromuscular, and Neurode-
generative Disorders Unit, Laboratory of Molecular Medicine,
Bambino Gesu’ Children’s Research Hospital, IRCCS, Rome;
Italian Department of Neurosciences and Rehabilitation, Institute
“G. Gaslini,” Genoa; and Department ofWomen’s and Children’s
Health, University of Padua, Padua). On the same morning, IC,
anthropometric measurements, and clinical examination were
performed for each patient at the ICANS center. The study
protocol received Institutional Review Board approvals (Ethics
Committee of the University of Milan n.7/16 and Carlo Besta
Neurological Institute Foundation n.37/2016) and completely
complied with the Helsinki Declaration. The parents, on behalf
of their children, gave their informed and written consent to the
study.
Study variables
The dependent variable was the measured REE (mREE,
kcal/d) by IC. The independent variables were categorized
into 3 groups: demographic, anthropometric, and clinical. The
demographic variables included age at study date and sex. The
anthropometric variables included body weight (BW, kg), supine
length (SL, m), tibia length (TL, cm), and BMI (BW/SL2, kg/m2).
The clinical variables included type of breathing: spontaneous
compared with mechanical ventilation (noninvasive mechanical
ventilation [NIV] or invasive ventilation-tracheostomy [IVT]),
type of feeding (oral compared with nasogastric tube or
gastrostomy), and the presence of nusinersen treatment (yes:
treated, ≥4 infusions; no: untreated). The clinical variables were
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collected by a pediatric neurologist (GB) 1 d before nutritional
and REE evaluation.
REE was also estimated using predictive equations (pREE).
The clinical data were prospectively collected and reported in
electronic medical records.
Measured REE
An open-circuit ventilated-hood system IC (VMAX Sensor
Medics 29) designed to measure VO2 (oxygen consumption)
and VCO2 (carbon dioxide production) from ventilation gases in
both spontaneously breathing and ventilated patients was used
to measure mREE. IC was calibrated daily before starting the
tests, using a 2-point calibration method based on 2 separate
mixtures of known gas content. The flow rate was calibrated
with a 3-liter syringe, according to the IC manufacturer’s
instructions.
Each measurement was done by 2 trained dietitians early or
late morning (between 09:00 and 13:00) after a 6-h fast for
patients under 1-y old, after a 12-h fast for patients older than
1 y, or after stopping continuous enteral feeding in tube-fed
children for 4 h to eliminate nutrient thermogenesis. Children laid
awake completely at rest supine on a bed in a thermally neutral
environment (24◦C) and were destressed by infant music or video
cartoons.
In spontaneously and NIV-supported breathing patients, gas
exchange was measured by a transparent ventilated canopy. To
avoid gas leakages, the subject’s headwas carefully wrappedwith
a plastic sleeve. Following the protocol validated by Siirala et al.
(20) in NIV-supported breathing patients, the expiration valve of
the ventilation mask was placed near the canopy’s aperture from
which the mixed gases were suctioned into the IC. In addition,
the plastic sleeve of the canopy was tucked carefully under the
pillow and wrapped around the inspiration tubing and along the
body of the child to minimize any leakage into the measurement
circuit.
In IVT patients, expired gas was collected from the expi-
ratory outlet of the ventilator by flexible tubing connected to
the IC.
A 15-min resting period was maintained before starting the
measurements in order to balance the mixing canopy of the
instrument with alveolar gas from the patient. Any breath values
with a >10% difference, reflecting an airway leak, were not
included in the calculation. Before the study, each patient was
suctioned to clear secretions from the trachea. This procedure
was approved by the IC manufacturer and had been previously
applied in REE assessment in mechanically ventilated patients in
several studies (21, 22).
Respiratory gas samples were taken for ≥20 min and the data
collected during the first 5 min were discarded, as recommended
by Isbell et al. (23). This allowed the subjects to acclimatize
themselves to the canopy and instrument noise. An air flow
value of 12 L/min was maintained for a weight range of 5–
10 kg and of 15 L/min when the child’s weight was over
10 kg.
A 5-min steady state was defined as the first 5 consecutive
stable 1-min readings with a coefficient of variation <5% for
VCO2 and VO2 (21, 24).
To calculate mREE, oxygen consumption and carbon dioxide
production were substituted into the modified Weir equa-
tion (25):
mREE (kcal/day) = [3.941VO2 (mL/min)
+1.106VCO2 (mL/min)] × 1.44 (1)
Patients ventilated (NIV or IVT) for <16 h a day performed
consecutive REE measurement both with and without the NIV
support. This approach enabled us to measure the effect of
ventilation support on REE.
The association between demographic, clinical, and anthropo-
metric variables with mREE was evaluated to test whether these
factors had a significant influence on energy expenditure.
Predicted REE
The mREE was then compared with the following published
REE prediction equations: 1) WHO (12), 2) Schofield (13), 3)
General Guidelines for SMA Children (16), and 4) Culley and
Middleton (26). The algorithm of each equation for the prediction
of REE is reported in Table 1.
Anthropometric variables
All anthropometric measurements were collected by 2 well-
trained dietitians and had been standardized by applying con-
ventional criteria (27) and recognized measuring procedures, as
described previously (28). Specifically, BW was measured using
a wheelchair scale to the nearest 100 g: the child and wheelchair
were weighed together, then the wheelchair was weighed alone,
and the difference in the 2 measurements gave the weight of the
subject. Infants with a BW of 5–7 kg were weighed in the arms
of a family member or observer, after which only the adult was
weighed, and the difference of the weights was obtained.
SL was measured in segments using a straight edge (Seca 210)
from the top of the head to the greater trochanter of the hip, from
the hip to the femoral epicondyle of the knee, and from the knee to
the distal point of the calcaneus. To identify the top of the head,
a vertical headboard was used, and the tape was positioned on
a line parallel to the sagittal plane, passing through the greater
trochanter of the hip (9).
BMI was calculated by the following formula: BW (kg)/SL2
(m2). Sex-specific weight, length, and BMI-Z-scores were
derived using the 2006 WHO Growth Standards (29). According
toWHOZ-score (SDS) cut-off points, BMI-for-age values below
–1.644 (5th percentile) were considered underweight, between –
1.644 and +1.036 normal weight, between +1.036 and +1.644
overweight, and above +1.644 obese.
TL, approximated to the nearest 0.5 cm, was taken along the
child’s left side by a nonelastic tape and with the child lying
supine on the exam table, as with the SL measurement. TL was
measured from the proximal end of the medial border of the tibia
to the distal tip of the medial malleolus (28).
Clinical variables
A medical history was collected to define the presence,
type, and duration of ventilatory support [spontaneous compared
with mechanical ventilation (NIV or IVT)] and feeding (oral
compared with nasogastric tube or gastrostomy). In patients
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TABLE 1 Predictive equations for calculating resting energy expenditure (kcal/d)
Girls Boys
WHO (12)
0–3 y REE = 60.9 × BW – 54 REE = 61 × BW – 51
3–10 y REE = 22.7 × BW + 495 REE = 22.4 × BW + 499
Schofield (BW) (13)
0–3 y REE = 59.48 × BW – 30.33 REE = 58.29 × BW – 31.05
3–10 y REE = 22.7 × BW + 505 REE = 20.3 × BW + 486
Schofield (BW&SL) (13)
0–3 y REE = 0.167 × BW + 15.174 × SL – 617.6 REE = 16.25 × BW + 10.232 × SL – 413.5
3–10 y REE = 19.6 × BW + 130.3 × SL + 414.9 REE = 16.97 × BW + 161.8 × SL + 371.2
General Guidelines for SMA Children (16, 18)
All ages REE = 9–11 kcal/ SL REE = 9–11 kcal/ SL
Culley & Middleton1 (26)
All ages REE = 11.1 kcal/ SL REE = 11.1 kcal/ SL
1Nonambulatory patients.
BW, body weight (kg); REE, resting energy expenditure; SL, supine length (cm); SMA, spinal muscular atrophy.
treated with nusinersen, the number of intrathecal infusions was
also collected.
Statistical analysis
Most continuous variables were not Gaussian distributed,
and all are reported as median (25th, 75th percentile). Discrete
variables are reported as the number and proportion of subjects
with the characteristic of interest.
We evaluated the contribution of age, BW, SL, and TL to
REE, separately in spontaneously breathing and mechanically
ventilated patients, using linear regression models adjusted for
nusinersen treatment (discrete: 0 = no; 1 = yes). Standard
diagnostic plots were used to evaluate model fit (30). Not
unexpectedly, age, BW, SL, and TL were collinear, so we did not
need to develop multivariable models. The adjusted coefficient
of determination (R2adj) and the root mean squared error of
the estimate (RMSE) were used as measures of model fit. The
95% CIs of the regression coefficients, R2adj, and RMSE were
calculated using bootstrap analysis on 1000 random samples
of 83 spontaneously breathing patients and 39 mechanically
ventilated patients. Bootstrap analysis offers an efficient way of
correcting for over optimism and is currently considered the best
method for internal crossvalidations (31).
Bias was calculated as (estimated REE – mREE) and
percentage bias as [(estimated REE – mREE)/mREE] ∗100 (32).
Bland–Altman plots of percentage bias [(pREE
– mREE)/average] compared with average bias
[(pREE + mREE)/2] were used to investigate the agreement
between currently available REE predictive equations and mREE
by IC.
The Wilcoxon rank sum test was used to compare mREE in
subpopulations determined by ventilation and nusinersen status.
Statistical analysis was performed using Stata 15.1 (Stata
Corporation).
Results
Demographic, clinical, and anthropometric variables
In total, 122 SMAI children (73 girls and 49 boys) were
included in the study. The median (25th, 75th percentile) age
was 13 (5, 25) mo. Thirty-four percent of the children (n = 42)
were on mechanical ventilation (22% with NIV and 12% with
IVT) and 31% were artificially fed (23% with percutaneous
endoscopic gastroscopy and 8% with a nasogastric tube). In
the whole sample, the median SDS of weight and BMI were –
1.46 and –2.35, respectively, corresponding to the 7th and 0.4th
percentiles of the WHO distribution. The median SDS of length
was 0.37, corresponding to the 64th percentile of the WHO
distribution.
Table 2 shows the demographic, clinical, and anthropometric
variables stratified by nusinersen and ventilatory status. In
both naïve and nusinersen-treated patients, we did not observe
significant differences in age and age-normalized variables
between spontaneously breathing and mechanically ventilated
patients.
Table 3 shows the measured and predicted values of REE as
absolute values (kcal/d) and normalized for kg of BW (kcal ·
d−1 · kg−1) in naïve and nusinersen-treated patients according to
ventilatory status.
In naïve patients, the median (25th, 75th percentile)
mREE was 480 (412, 575) compared with 394 (281,
554) kcal/d in spontaneously breathing and mechanically
ventilated patients, respectively (P = 0.009). The median
(25th, 75th percentile) mREE was 63 (54, 71) compared
with 51 (19, 61) kcal/d per kg of BW in spontaneously
breathing and mechanically ventilated patients, respectively
(P <0.001).
By contrast, in nusinersen-treated patients, the median (25th,
75th percentile) mREE was 609 (592, 702) compared with 639
(479, 723) kcal/d in spontaneously breathing and mechanically
ventilated patients, respectively (P = 0.949). The median (25th,
75th percentile) mREEwas 66 (58, 76) comparedwith 67 (56, 76)
kcal/d per kg of BW in spontaneously breathing andmechanically
ventilated patients, respectively (P = 0.925).
Influence of demographic, anthropometric, and clinical
variables on mREE values
To test whether age, BW, SL, TL, ventilatory status, and nusin-
ersen treatment had a significant impact on energy expenditure,
we plotted in Figure 1 the relations between these variables and
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FIGURE 1 Relation between age, weight, body, and tibia length and measured resting energy expenditure (mREE) according to the ventilatory status (yes
compared with no) and nusinersen treatment (yes compared with no). A) Plots the relation between age, weight, supine and tibia length, and mREE according
to the ventilatory status (yes compared with no). B) Plots the relation between age, weight, supine and tibia length, and mREE according to the nusinersen
treatment (yes compared with no). Children with mechanical ventilation (noninvasive mechanical ventilation or invasive ventilation-tracheostomy) have been
considered ventilated. Children with ≥4 infusions have been considered treated. REE, resting energy expenditure.
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FIGURE 2 Difference between measured resting energy expenditure (kcal/d) with and without mechanical ventilation during the same session in 10
subgroup children. REEvent, measured resting energy expenditure with mechanical ventilation; REEnovent, measured resting energy expenditure in spontaneous
breathing.
mREE according to the ventilatory status (yes compared with no)
and nusinersen treatment (yes compared with no).
Ventilated patients had a lower REE in relation to all
independent variables considered, whereas patients treated with
nusinersen had a higher REE than the untreated ones. The
magnitude of ventilation status effect on mREE was also
evaluated in a subsample of 10 children, by measuring REE
with and without the artificial ventilator during the same
session. Figure 2 plots the difference between the estimated
REE with and without the artificial ventilator during the same
session for each child. The median difference between the
estimated and measured REE in the 10 children was –305 kcal/d,
with a within-children difference ranging from –594 to
–218 kcal/d.
Development of population-specific REE equations
Table 4 gives the regression models used to develop
population-specific equations for spontaneously breathing and
mechanically ventilated SMAI patients.
Spontaneously breathing patients
The best prediction of REE was obtained from models M2,
M3, and M4.
ModelM2 employs BWand nusinersen treatment as predictors
and explains 63% (bootstrapped 95% CI: 48, 79%) of REE
variance with an RMSE of 86 (bootstrapped 95% CI: 72, 101)
kcal/d. The corresponding equation is:
REE (kcal/d)
=35∗BW (kg) +75∗nusinersen treatment (1=yes)+219 (2)
Model M3 employs SL and nusinersen treatment as predictors
and explains 63% (bootstrapped 95% CI: 47, 79%) of REE
variance with an RMSE of 85 (bootstrapped 95% CI: 69, 101)
kcal/d. The corresponding equation is:
REE (kcal/d)
=6∗SL (cm) +75∗nusinersen treatment (1=yes)+10 (3)
Model M4 employs TL and nusinersen treatment as predictors
and explains 62% (bootstrapped 95% CI: 48, 76%) of REE
variance with an RMSE of 88 (bootstrapped 95% CI: 74, 102)
kcal/d. The corresponding equation is:
REE (kcal/d)
=24∗TL (cm) +97∗nusinersen treatment (1= yes)+179 (4)
Models M2, M3, and M4 gave identical measures of model fit
due to the fact that weight and SL are virtually surrogatemeasures
(Spearman’s rho = 0.85, P <0.0001).
Mechanically ventilated patients
The best prediction of REE was obtained from model M8 and,
subsequently, from model M5, M6, and M7.
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Model M8 employs TL and nusinersen treatment as predictors
and explains 22% (bootstrapped 95% CI: 0, 45%) of REE
variance with an RMSE of 197 (bootstrapped 95% CI: 159, 234)
kcal/d. The corresponding equation is:
REE (kcal/d)
=14∗TL(kg) +200∗nusinersen treatment (1 =yes)+190 (5)
An REE calculator (https://jscalc.io/calc/Q91zp6clkwI9PVB
n) can be used as a further aid.
Accuracy of tested and new population-specific equations to
predict REE
Table 5 reports the bias and percentage bias of the tested and
the new population-specific equations stratified for nusinersen
and ventilatory status.
In both naïve and nusinersen-treated patients, the Culley
and Middleton equation for nonambulatory patients had the
highest median (25th, 75th percentile) percentage bias [77% (56–
112%) compared with 44% (33–68%), respectively] followed by
the General Nutrition Guidelines for Spinal Muscular Atrophy
(SMAGNG) equation [43% (27–72%) compared with 16% (8–
37%), respectively], even when we considered ventilation status.
Both equations are based on SL: their use in SMA patients leads
to considerable overestimation of REE. SL contribution on REE
ranged from 9 to 11.1 kcal/cm in the Culley and Middleton and
SMAGNG equations (16, 26), whereas in our equations it was
only 6 (95%CI: 5, 8) kcal/cm in spontaneously breathing patients
and 2 (95% CI: 0, 4) kcal/cm in mechanically ventilated patients,
as shown in Table 4. The Schofield BWand SL equations (13) had
the lowest median percentage bias in nusinersen-treated patients
(both in spontaneously breathing and mechanically ventilated
patients) and in naïve spontaneously breathing patients. Overall,
the WHO equation performed better than the other equations,
with low median percentage bias in all subpopulation groups.
Figure 3 shows Bland and Altman plots for each REE
predictive equation compared with measured REE stratified for
nusinersen and ventilatory status. Differences were not normally
distributed for any equation (Shapiro–Wilk normality test), so
limits of agreement were not computed. These plots add to the
results from Table 5, revealing a proportional bias affecting even
equations with a low median bias.
Discussion
To our knowledge, this is the first study to develop population-
specific predictive energy equations for naïve and nusinersen-
treated SMAI children breathing spontaneously or on mechanical
ventilation with a higher accuracy than the existing equations. It
is common practice in healthy subjects and neurological patients
(12, 13, 26) to only include demographic and anthropometric
variables (e.g., sex, weight, length) in REE predictive equations.
Based on the results of this study, the addition of nusinersen
treatment produced a better fitting model of mREE in SMAI.
One of the most important findings is the critical role of
ventilatory status on mREE in SMAI children. We investigated
its contribution in 2 different ways: firstly, by plotting the
relations between demographic, clinical, and anthropometric
variables and mREE according to the ventilatory status (yes
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TABLE 5 Bias and percentage bias of tested and new population-specific equations
Naïve Nusinersen
Spontaneous
breathing
Mechanical
ventilation Total
Spontaneous
breathing
Mechanical
ventilation Total
N = 73 N = 26 N = 99 N = 10 N = 13 N = 23
Predicted resting energy expenditure
Bias Schofield BW, kcal/d − 53 (−114, 11) 33 (−47, 471) − 40 (−103, 27) − 98 (−177, −26) − 62 (−152, 71) − 95 (−172, 8)
Bias Schofield BW, % − 12 (−24, 3) 8 (−14, 151) − 7 (−23, 6) − 18 (−27, −4) − 13 (−25, 11) − 14 (−26, −1)
Bias Schofield BW and SL, kcal/d − 18 (−61, 54) 206 (0, 555) 13 (−57, 83) − 38 (−81, 29) − 33 (−104, 93) − 38 (−87, 73)
Bias Schofield BW and SL, % − 4 (−13, 9) 45 (0, 204) 2 (−12, 20) − 4 (−13, 5) − 5 (−13, 16) − 5 (−13, 12)
Bias WHO, kcal/d − 65 (−119, 20) 49 (−50, 572) − 38 (−107, 42) − 95 (−190, −23) − 71 (−148, 75) − 90 (−185, −8)
Bias WHO, % − 13 (−26, 5) 8 (−11, 144) − 8 (−25, 8) − 17 (−28, −3) − 15 (−25, 17) − 15 (−27, −1)
Bias SMAGNG, kcal/d 185 (135, 241) 299 (188, 684) 198 (142, 280) 87 (63, 130) 140 (54, 277) 104 (56, 214)
Bias SMAGNG, % 37 (26, 55) 79 (45, 259) 43 (27, 72) 14 (9, 23) 24 (8, 46) 16 (8, 37)
Bias Culley & Middleton,1 kcal/d 343 (283, 394) 477 (353, 846) 352 (302, 447) 250 (248, 305) 322 (231, 474) 276 (246, 376)
Bias Culley & Middleton,1 % 70 (56, 91) 121 (79, 343) 77 (56, 112) 41 (34, 51) 322 (231, 474) 44 (33, 68)
New population-specific Equations
Bias M1, kcal/d 4 (−67, 55) 4 (−67, 55) − 9 (−46, 44) − 9 (−46, 44)
Bias M1, % 1 (−13, 14) 1 (−13, 14) − 1 (−7, 5) − 2 (−8, 5)
Bias M2, kcal/d 9 (−55, 50) 9 (−55, 50) − 13 (−68, 55) − 13 (−68, 55)
Bias M2, % 2 (−10, 10) 2 (−10, 10) − 2 (−9, 9) − 2 (−8, 9)
Bias M3, kcal/d 0 (−49, 62) 0 (−49, 62) − 28 (−66, 20) − 28 (−66, 20)
Bias M3, % 0 (−9, 12) 0 (−9, 12) − 5 (−11, 4) − 5 (−11, 4)
Bias M4, kcal/d 10 (−52, 43) 10 (−52, 43) − 4 (−60, 35) − 4 (−60, 35)
Bias M4, % 2 (−10, 10) 2 (−10, 10) − 1 (−9, 6) 0 (−9, 6)
Bias M5, kcal/d 8 (−162, 194) 8 (−162, 194) − 45 (−122, 105) − 45 (−122, 105)
Bias M5, % 3 (−27, 69) 3 (−27, 69) − 7 (−17, 22) − 7 (−17, 22)
Bias M6, kcal/d 4 (−142, 191) 5 (−142, 191) − 39 (−111, 110) − 39 (−111, 110)
Bias M6, % 2 (−25, 65) 2 (−25, 65) − 6 (−16, 23) − 6 (−16, 23)
Bias M7, kcal/d 1 (−152, 183) 1 (−152, 183) − 44 (−108, 52) − 45 (−108, 52)
Bias M7, % 1 (−26, 65) 1 (−26, 65) − 6 (−15, 10) − 7 (−15, 10)
Bias M8, kcal/d 2 (−120, 175) 2 (−120, 175) − 33 (−103, 87) − 33 (−103, 87)
Bias M8, % 1 (−21, 67) 0 (−21, 67) − 5 (−14, 18) − 5 (−14, 18)
Data are presented as median (25th, 75th percentile).
1Non-ambulatory patients.
BW: body weight (kg); M1: linear regression model employing age and nusinersen treatment in spontaneous breathing; M2, linear regression model
employing weight and nusinersen treatment in spontaneous breathing; M3, linear regression model employing supine length and nusinersen treatment in
spontaneous breathing; M4, linear regression model employing tibia length and nusinersen treatment in spontaneous breathing; M5, linear regression model
employing age and nusinersen treatment in mechanical ventilation; M6, linear regression model employing weight and nusinersen treatment in mechanical
ventilation; M7, linear regression model employing supine length and nusinersen treatment in mechanical ventilation; M8, linear regression model employing
tibia length and nusinersen treatment in mechanical ventilation; SL, supine length (cm); SMA, spinal muscular atrophy; SMAGNG, General Nutrition
Guidelines for Spinal Muscular Atrophy.
compared with no); secondly, by measuring REE with and
without mechanical ventilation during the same session in
children not completely dependent on ventilatory support. With
the first approach we demonstrated that artificial ventilation
always significantly reduces mREE regardless of the other
variables considered. With the second approach, we proved that
the use of ventilation reduced energy needs by >50%. The
magnitude of the effect of the ventilatory status on energy
requirements can be explained by the very specific thoracic-
abdominal patterns of respiration in SMA (particularly in SMAI)
(33–36). Lo Mauro et al. performed a kinematic analysis of
thoracic-abdominal movements of SMA patients both during
spontaneous breathingand mechanical ventilation, showing that
SMA patients had a paradoxical ventilation pattern during
spontaneous respiration that disappeared during mechanical
ventilation. This was seemingly due to the normalization of kine-
matic volume changes during alveolar ventilation, significantly
reducing the energy expenditure for respiratory work (33, 37).
Our previous observation that SMAI children have signifi-
cantly higher REE per kg of FFM than SMA type II (SMAII)
children (10) supports the hypothesis that greater impairment of
intercostal muscles in SMAI requires greater energy expenditure
to perform respiratory work (33–36).
Few studies have evaluated the impact of mechanical ven-
tilation on REE and no studies in SMA patients are avail-
able. Gonzalez-Bermejo et al. (38) investigated the impact
of mechanical ventilation on REE in adult patients affected
by Duchenne muscular dystrophy, a severe type of muscular
dystrophy characterized by progressive muscle degeneration and
increased difficulty in breathing in the last phase of disease,
as occur in SMAI patients just at the onset of disease. They
found that the mean difference between REE in spontaneous
and mechanical ventilation was 19% (38). We have found a
much greater REE reduction but it should also be taken into
consideration that the respiratory rate declines from birth to early
adolescence. The median respiratory rate decreases by >40%
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FIGURE 3 Relative Bland–Altman plots of currently available predictive equations compared with measured resting energy expenditure. Wt, weight; Ht,
height; REE, resting energy expenditure; SMAGNG, General Nutrition Guidelines for Spinal Muscular Atrophy; Wt, weight. Schofield (Wt) in naïve patients
in spontaneous breathing: N = 73. Schofield (Wt) in naïve patients in mechanical ventilation: N = 25. Schofield (Wt) in patients treated with nusinersen in
spontaneous breathing: N = 10. Schofield (Wt) in patients treated with nusinersen in mechanical ventilation: N = 13. Schofield (Wt&t) in naïve patients in
spontaneous breathing: N = 73. Schofield (Wt&t) in naïve patients in mechanical ventilation: N = 25. Schofield (Wt&t) in patients treated with nusinersen in
spontaneous breathing: N= 10. Schofield (Wt&t) in patients treated with nusinersen in mechanical ventilation: N= 13. WHO in naïve patients in spontaneous
breathing: N = 73. WHO in naïve patients in mechanical ventilation: N = 25. WHO in patients treated with nusinersen in spontaneous breathing: N = 10.
WHO in patients treated with nusinersen in mechanical ventilation: N= 13. SMAGNG in naïve patients in spontaneous breathing: N= 73. SMAGNG in naïve
patients in mechanical ventilation: N = 25. SMAGNG in patients treated with nusinersen in spontaneous breathing: N = 10. SMAGNG in patients treated
with nusinersen in mechanical ventilation: N = 13. Culley & Middleton (Ht) in naïve patients in spontaneous breathing: N = 73. Culley & Middleton (Ht)
in naïve patients in mechanical ventilation: N = 25. Culley & Middleton (Ht) in patients treated with nusinersen in spontaneous breathing: N = 10. Culley
& Middleton (Ht) in patients treated with nusinersen in mechanical ventilation: N = 13. Ht, height; REE, resting energy expenditure; SMAGNG, General
Nutrition Guidelines for Spinal Muscular Atrophy; Wt, weight.
changing from 44 breaths/min at birth to 20 breaths/min at adult
age (39). Our sample may have a greater energy expenditure
for respiratory work than that observed in Duchenne muscular
dystrophy adult patients because of its median (25th, 75th
percentile) age [13 (5, 25 mo)].
Interestingly, when we analyzed naïve and nusinersen-
treated patients separately, we observed that, in naïve patients,
mechanical ventilation significantly reduced total mREE and
normalized REE for BW. By contrast, mechanical ventilation
did not affect REE in nusinersen-treated patients. Other studies
are needed to better understand the role of respiratory work on
energy expenditure in SMA patients. These considerations led
us to develop 2 sets of predictive equations, 1 for spontaneous
breathing and 1 for mechanical ventilation, including treatment
of nusinersen as a predictor of REE.
To the best of our knowledge, this is the first study that de-
scribes the effect of nusinersen treatment on energy metabolism.
We demonstrated that nusinersen treatment always significantly
increases mREE irrespective of the other considered variables,
as shown in the different models, suggesting a potential positive
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effect of nusinersen treatment on FFM. Future longitudinal
studies on the effect of nusinersen on energy metabolism are
needed to confirm this hypothesis.
Age, BW, SL, and TL were also significantly correlated with
mREE in this study. Even though FFM should be a stronger
predictor of mREE, it is of limited clinical utility to dietitians
and physicians, as few clinics have access to gold standard
methods for the assessment of body composition. For this reason,
in the predictive models we included BW or SL, which are
recommended for a 6-monthly assessment according to the
standard of care (16, 18), and are easily obtained in clinical
settings, making them a suitable alternative for FFM.
Unsurprisingly, the nutritional status in our overall sample was
significantly impaired, with BW Z-score and BMI Z-score mean
values indicating malnutrition. On the other hand, the SL Z-
score was in line with or over the median values of the reference
group. These data confirm results from previous studies (5, 10,
40, 41) and support the hypothesis that, compared with healthy
children (10), SMAI children have high FM and low FFM as a
consequence of their underlying neurological condition, and not
due to insufficient energy intake.
Our nusinersen-treated patients showed an SL Z-score lower
than naïve patients, confirming previous results on decreased
growth (height/length) among nusinersen-treated infants com-
pared with sham controls (42).
Because of the well-known difficulties in obtaining accurate
and repeatable measurements of SL in neuromuscular patients
due to scoliosis and contractures (43), we also considered TL,
which is a surrogate parameter of SL (44–46). In spontaneously
breathing SMAI patients, the use of SL produces a better fitting
model of mREE than TL. On the other hand, the use of TL
produces a more suitable model of mREE in mechanically
ventilated SMAI patients. However, scoliosis and contractures
in SMAI patients occur more frequently at a later age than the
children enrolled in this study, so these results should be verified
in older children.
The present study compared the predicted REE from other
published predictive equations (12, 13, 16, 26) with measured
mREE from IC. We found that none of the predictive equations
were sufficiently accurate to estimate the REE in these patients.
Regarding median bias in spontaneously breathing patients,
the WHO and Schofield equations (12, 13) performed best in
estimating REE, but the proportional bias was too large to ensure
proper management of nutritional support at the individual level.
In nusinersen-treated spontaneously breathing patients, Schofield
(BW and SL) performed particularly well, showing that this
subpopulation is the closest to the general population.
Only 3 previous studies have compared mREE in SMA
children with published REE predictive equations proposed for
healthy children, but they were all conducted before the approval
of nusinersen treatment. Cutillo et al. (47) investigated the
differences between predicted (Schofield BW and SL equation,
Schofield BW and WHO equations) and observed measures
for REE in 18 Caucasian children affected by SMAII. They
evaluated the largest deviation from the measured value using an
overall average value of difference between the predictive and the
measured REE – all the equations had a bias large enough to be
potentially dangerous in the management of nutritional support.
Similar results were also obtained in 7 SMA patients by Barja et
al. (15). These results also confirmed our findings in SMAI and
in SMAII where the Schofield equation overestimated REE by
>20% (10).
Finally, the predictive equation for mental and motor disabili-
ties in children (26) and the equation proposed by the SMAGNG
(16), overestimated the contribution of SL on REE in our children
by 3–9 kcal/cm, showing a higher bias than the equations for
healthy children. The bias in Culley and Middleton may be
attributable to the specific body composition and motor function
features of SMAI children, who unlike other patients with motor
dysfunction disabilities, have not only low FFM but also severe
hypotonia (26).
When we compared our new predictive equations with others
previously published (12, 16, 26), we found a better validity
of the new equations in SMA children than any of the other
equations. This was of course expected, because an internally
developed equation nearly always performs better than an
externally derived one. Thus, our SMAI-specific equations need
external crossvalidation before they can be employed in clinical
practice.
The greatest strength of this study is both the relatively
large sample size of treated and naïve SMA patients, and the
quality of data; it included patients from an ongoing longitudinal
study on nutritional aspects in SMA children which enabled
us to prospectively collect the parameters with standardized
procedures by the same dietitians (28). In addition, REE was
measured under strictly controlled conditions and by a single
center. Despite our original findings (10), the SMAI population
is heterogeneous and patients may have a large metabolic
interindividual variability; this increases the difficulty of finding
1 predictive equation that can be accurate for all patient types.
In conclusion, we highlighted that ventilatory status and
nusinersen treatment, as well as demographic and anthropometric
characteristics, determine energy requirements in SMAI patients.
In particular, we demonstrated that nusinersen treatment is
correlated with higher REE both in spontaneously breathing and
mechanically ventilated patients.
Our new equations were more accurate than any of the other
previously published equations; however, they explain 62–63%
and 18–22% of REE variance in spontaneously breathing and
mechanically ventilated children, respectively, leading us to
the conclusion that IC is strongly recommended for assessing
energy requirements in SMAI children. Nonetheless, IC devices
are rarely available in clinics; our SMAI-specific equations,
that include variables readily available in clinical practice, may
allow dietitians and physicians to optimize the management of
nutritional support, also taking into consideration ventilatory
status and nusinersen treatment. Further research is needed to
perform external validation of these equations.
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